drugset / Trial / NCT03052361

Triage Administration of Ondansetron for Gastroenteritis in Children

NCT03052361 ↗

Phase 2/3 Terminated 81 enrolled St. Justine's Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The investigators aim to assess whether ondansetron given at triage can reduce the number of patients requiring emergency department observation in children with acute gastroenteritis. The investigators will also assess the improvement of patient comfort and total length of stay

Timeline

Start
2017-07-15
Primary completion
2020-09-03
Completion
2020-10-03

Outcome

Outcome not reported

Stopped (Enrollment): “The recruitment was much slower than expected and the COVID pandemic added new barriers to recruitment.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Ondansetron Other / unclassified 2 mg —
Subject Ondansetron Other / unclassified 4 mg —
Subject Ondansetron Other / unclassified 8 mg —

Indications